Viewing Study NCT06181331



Ignite Creation Date: 2024-05-06 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06181331
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-26
First Post: 2023-12-12

Brief Title: The Effect of a Stepped-care Metacognition-based Intervention on Managing Fear of Cancer Recurrence
Sponsor: The University of Hong Kong
Organization: The University of Hong Kong

Study Overview

Official Title: The Effect of a Stepped-care Metacognition-based Intervention on Managing Fear of Cancer Recurrence Sequential Multiple Assignment Randomized Controlled Trial SMARTs
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A sequential multiple-assignment randomized controlled trial SMART will be used to assess the effect of an adaptive stepped-care intervention on FCR in cancer survivors with subclinical levels of fear of cancer recurrence
Detailed Description: The current SMART trial aims to address the following hypotheses

Hypothesis 1 It is better to begin adaptive interventions with eConquerFear than with eHealthMaintenance

Hypothesis 2 Among initial non-respondents it is better to switch to supervised face-to-face ConquerFear than to augment eConquerFear with eHealthMaintenance

Hypothesis 3 eConquerFear ConquerFear will lead to the greatest reduction in fear of cancer recurrence

Hypothesis 4 There would be an indirect effect of stepped-care ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition and cognitive attentional syndrome

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None